Invesco Biotechnology & Genome ETF Rating $70.51 -1.04 (-1.45%) As of 02:22 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Invesco Biotechnology & Genome ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PBE Aggregate RatingModerate Buy 2.61Holdings in PBE have an aggregate rating of Moderate Buy based on 438 analyst ratings issued in the past year covering 25 companies (88.2% of the portfolio).PBE Aggregate Price Target$70.51High Prediction$70.51Average Prediction$70.51Low Prediction$70.51Holdings in PBE have an aggregate price target of $70.51 and a range of $70.51 to $70.51 covering 25 companies (88.2% of the portfolio).PBE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Biotechnology & Genome ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 PBE Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.95%BIIBBiogen$145.33-2.9%4.6607 of 5 stars2.32$180.15 24.0%31Trending NewsAnalyst ForecastAnalyst Revision4.92%INCYIncyte$83.49-1.5%4.507 of 5 stars2.22$84.79 1.6%18Analyst Forecast4.88%RPRXRoyalty Pharma$36.18+0.1%4.8466 of 5 stars3.20$46.00 27.1%5Analyst Upgrade4.87%GILDGilead Sciences$117.26+0.4%4.8943 of 5 stars2.86$118.08 0.7%29Trending NewsAnalyst ForecastAnalyst Revision4.82%REGNRegeneron Pharmaceuticals$558.04-2.1%4.7218 of 5 stars2.79$817.46 46.5%29Positive NewsAnalyst ForecastAnalyst Revision4.78%VRTXVertex Pharmaceuticals$407.15-1.9%4.8159 of 5 stars2.62$494.38 21.4%29Positive NewsAnalyst Forecast4.74%AMGNAmgen$290.76-1.6%4.553 of 5 stars2.35$309.42 6.4%20Positive NewsAnalyst UpgradeAnalyst Revision4.70%ILMNIllumina$93.18-3.4%4.7485 of 5 stars2.15$123.56 32.6%20Analyst Forecast4.06%IONSIonis Pharmaceuticals$69.89-0.5%3.4868 of 5 stars2.80$78.28 12.0%20Trending NewsAnalyst ForecastInsider Trade3.80%UTHRUnited Therapeutics$442.45-0.7%4.3219 of 5 stars2.67$457.21 3.3%15Analyst ForecastInsider Trade3.51%MNKDMannKind$4.85-5.7%4.0519 of 5 stars2.89$10.86 124.1%9News CoveragePositive NewsAnalyst ForecastHigh Trading Volume3.22%PTCTPTC Therapeutics$66.68+1.0%3.3324 of 5 stars2.53$69.00 3.5%15Analyst ForecastInsider Trade3.09%EXASExact Sciences$58.71-1.3%4.4741 of 5 stars2.92$69.19 17.9%24News CoverageAnalyst Forecast3.01%VCYTVeracyte$34.57-1.0%3.6359 of 5 stars2.67$40.90 18.3%12Analyst ForecastInsider Trade2.87%NBIXNeurocrine Biosciences$137.40-0.8%4.7943 of 5 stars2.80$163.44 19.0%20Analyst Forecast2.78%HALOHalozyme Therapeutics$63.99-1.7%4.7643 of 5 stars2.31$70.44 10.1%13Trending NewsAnalyst UpgradeAnalyst Revision2.72%EXELExelixis$38.08-1.3%4.8584 of 5 stars2.63$44.42 16.6%24Trending NewsAnalyst ForecastAnalyst Revision2.69%MDGLMadrigal Pharmaceuticals$435.44+1.7%4.5106 of 5 stars2.73$525.88 20.8%11Positive NewsAnalyst Forecast2.68%SRPTSarepta Therapeutics$22.33-3.4%4.5675 of 5 stars2.03$34.42 54.1%29Analyst Forecast2.65%CPRXCatalyst Pharmaceuticals$20.53-1.4%4.8014 of 5 stars3.00$33.20 61.8%9Analyst ForecastBuyback Announcement2.56%DVAXDynavax Technologies$10.05-2.9%4.5052 of 5 stars2.20$24.33 142.2%5Positive NewsAnalyst Forecast2.51%BMRNBioMarin Pharmaceutical$52.05-3.3%4.9561 of 5 stars2.55$93.26 79.2%22Positive NewsAnalyst ForecastAnalyst Revision2.47%QGENQiagen$46.74-0.4%4.3983 of 5 stars2.25$49.40 5.7%12News CoverageAnalyst Forecast2.44%COLLCollegium Pharmaceutical$31.95-3.8%4.1788 of 5 stars3.00$42.33 32.5%5Analyst Forecast2.43%BCRXBioCryst Pharmaceuticals$7.21-0.6%4.0995 of 5 stars2.75$16.30 126.2%12Analyst Forecast This page (NYSEARCA:PBE) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersThe $20 stock that could make silicon chips obsoleteWhen a new chip can run at the speed of light, the game changes. This is the reality of “TF3” — a man-made...The Oxford Club | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Biotechnology & Genome ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
